FSLSX
Price
$55.18
Change
+$0.29 (+0.53%)
Updated
Jul 3 closing price
Net Assets
1.7B
VMVAX
Price
$86.72
Change
+$0.20 (+0.23%)
Updated
Jul 3 closing price
Net Assets
29.95B
Interact to see
Advertisement

FSLSX vs VMVAX

Header iconFSLSX vs VMVAX Comparison
Open Charts FSLSX vs VMVAXBanner chart's image
Fidelity Value Strategies
Price$55.18
Change+$0.29 (+0.53%)
VolumeN/A
Net Assets1.7B
Vanguard Mid-Cap Value Index Admiral
Price$86.72
Change+$0.20 (+0.23%)
VolumeN/A
Net Assets29.95B
FSLSX vs VMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSLSX vs. VMVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLSX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 29.9B vs. FSLSX (1.7B). VMVAX pays higher dividends than FSLSX: VMVAX (2.26) vs FSLSX (0.77). FSLSX was incepted earlier than VMVAX: FSLSX (42 years) vs VMVAX (14 years). FSLSX (0.80) is less costly to investors than VMVAX (0.07). FSLSX is a more actively managed with annual turnover of: 61.00 vs. VMVAX (19.00). FSLSX has a lower initial minimum investment than VMVAX: FSLSX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 12.14 vs. FSLSX (-2.02). FSLSX return over 5 years is better than : 85.30 vs. VMVAX (77.08).
FSLSXVMVAXFSLSX / VMVAX
Total Expense Ratio0.800.071,143%
Annual Report Gross Expense Ratio0.800.071,143%
Fund Existence42 years14 years-
Gain YTD0.8593.57324%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B29.9B6%
Annual Yield % from dividends0.772.2634%
Returns for 1 year-2.0212.14-17%
Returns for 3 years22.7728.5280%
Returns for 5 years85.3077.08111%
Returns for 10 years27.1288.1131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHFF1.300.01
+0.78%
Arch Biopartners Inc.
SBKO14.15N/A
N/A
Summit Bank Group, Inc.
CEVMF125.65N/A
N/A
CTS Eventim AG & Co. KGAA
NICFF22.86N/A
N/A
Nichias Corp.
ADYEY18.00-0.01
-0.06%
Adyen N.V.